EUVIMEDObjevte EUVIMED
Open access

Deep Learning Prediction of Antimicrobial Peptides in Protozoa

Fabiano Pinheiro da Silva, Suely Kubo Ariga, Thais Martins de Lima, João Marcelo Pereira Alves

Journal of Parasitology · 2026

DOI: 10.1645/25-99 ↗

At a glance

Journal article in Journal of Parasitology, 2026. Written by Fabiano Pinheiro da Silva and 3 co-authors. Major MEDLINE topics: Antimicrobial Peptides, Deep Learning, Protozoan Proteins, Eukaryota. 26 references. The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Antimicrobial resistance has become a major global health challenge, creating an urgent need for novel anti-infective molecules. Antimicrobial peptides (AMPs) constitute a promising alternative to conventional antibiotics because of their broad-spectrum antimicrobial activity and immunomodulatory properties. Despite the remarkable diversity of protozoa, very few protozoan AMPs have been experimentally identified. Here, we employed the deep learning algorithm AMPlify to systematically screen the proteomes of Blastocystis hominis, Trypanosoma cruzi, Leishmania major, Toxoplasma gondii, and Entamoeba histolytica for high-confidence AMP candidates. Candidate proteins with prediction probabilities greater than 0.90 were further annotated by sequence similarity searches and prioritized for experimental validation. We identified 48 candidate AMPs in B. hominis, 27 in T. cruzi, 23 in T. gondii, and 24 in E. histolytica, whereas no high-confidence candidates were detected in L. major. Predicted candidates represented diverse functional classes, including ribosomal proteins, enzymes, membrane-associated proteins, and proteins involved in nucleic acid metabolism. Three peptides were synthesized and evaluated against Escherichia coli K12. Among them, a peptide derived from the 60S ribosomal protein L3 of B. hominis inhibited bacterial growth with a minimum inhibitory concentration of 125 µM, whereas peptides derived from ribosomal protein L8 and T. cruzi trans-sialidase showed no detectable activity. These findings demonstrate the utility of deep learning for prioritizing novel AMP candidates while highlighting the importance of experimental validation. The identified candidates provide a valuable resource for future functional studies and the development of peptide-based antimicrobial therapeutics.

Subjects

MeSH terms (MEDLINE)

Antimicrobial PeptidesDeep LearningProtozoan ProteinsEukaryotaEntamoeba histolyticaToxoplasmaPrediction AlgorithmsEscherichia coliProteomeTrypanosoma cruziAnimalsLeishmania majorPredictive Learning Models

Author keywords

Antimicrobial peptidesAntimicrobial resistanceMachine learningProtozoa

Substances

Antimicrobial PeptidesProtozoan ProteinsProteome

Cite

APA

Pinheiro da Silva, F., Ariga, S. K., de Lima, T. M., & Alves, J. M. P. (2026). Deep Learning Prediction of Antimicrobial Peptides in Protozoa. Journal of Parasitology. https://doi.org/10.1645/25-99

Vancouver

Pinheiro da Silva F, Ariga SK, de Lima TM, Alves JMP. Deep Learning Prediction of Antimicrobial Peptides in Protozoa. Journal of Parasitology. 2026. doi:10.1645/25-99

BibTeX
@article{PinheirodaSilva2026,
  author = {Pinheiro da Silva, Fabiano and Ariga, Suely Kubo and de Lima, Thais Martins and Alves, João Marcelo Pereira},
  title = {Deep Learning Prediction of Antimicrobial Peptides in Protozoa},
  journal = {Journal of Parasitology},
  year = {2026},
  doi = {10.1645/25-99}
}
Start for free →